<h4>Unlabelled</h4><h4>Purpose</h4>Long-term continuous imatinib is recommended for adult patients with unresectable and/or metastatic KIT+ gastrointestinal stromal tumors (GIST) as long as the patient continues to benefit. Here, KIT is linked to gastrointestinal stromal tumor.